CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease

Abroad (travel likely)RecruitingPHASE3

Conditions

End Stage Renal Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California Davis Health, Sacramento, California, United States
Contact: Study coordinator (Geraldine Portillo) · gbportillo@ucdavis.edu
Vanderbilt University Medical Center-GCRC, Nashville, Tennessee, United States
Contact: Study coordinator (Delia Woods, RN) · delia.woods@vumc.org

Study leads

Jorge Gamboa, MD/PhD
Principal Investigator
VUMC
Talat Ikizler, MD
Principal Investigator
VUMC
Baback Roshanravan, MD/MPH
Principal Investigator
University of California, Davis

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia · Chronic Kidney Disease Requiring Chronic Dialysis · End Stage Renal Disease on Dialysis

Abroad (travel likely)RecruitingPHASE2

Huntsville, United States · Chula Vista, United States

EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease

Heart Failure With Preserved Ejection Fraction · End Stage Renal Disease on Dialysis

Abroad (travel likely)RecruitingPHASE4

Hsinchu, Taiwan · Taipei, Taiwan

Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease

Heart Failure with Reduced Ejection Fraction · End Stage Renal Disease on Dialysis

Abroad (travel likely)RecruitingPHASE4

Hsinchu, Taiwan · Taipei, Taiwan

Pumpkin Seed Oil as a Nutraceutical for Hemodialysis Patients

End Stage Renal Disease · Chronic Kidney Disease Requiring Chronic Dialysis · Inflammation

Abroad (travel likely)Recruiting

Baghdad, Iraq